Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2005 1
2006 2
2007 7
2008 14
2009 8
2010 17
2011 22
2012 17
2013 36
2014 34
2015 46
2016 55
2017 50
2018 54
2019 62
2020 93
2021 99
2022 87
2023 74
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

700 results

Results by year

Filters applied: Review, Systematic Review. Clear all
Page 1
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis.
Castillo-Núñez Y, Almeda-Valdes P, González-Gálvez G, Arechavaleta-Granell MDR. Castillo-Núñez Y, et al. Curr Diab Rep. 2024 May 3. doi: 10.1007/s11892-024-01542-6. Online ahead of print. Curr Diab Rep. 2024. PMID: 38700793 Review.
This review emphasizes the potential mechanisms linking MASLD with atherosclerosis and the possible causal relationships between these conditions. RECENT FINDINGS: An increased risk of cardiovascular disease is related to MASLD. Several molecular, cellular, and meta …
This review emphasizes the potential mechanisms linking MASLD with atherosclerosis and the possible causal relationships between these condi …
A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action.
Zhang S, Ren X, Zhang B, Lan T, Liu B. Zhang S, et al. Molecules. 2024 Apr 19;29(8):1859. doi: 10.3390/molecules29081859. Molecules. 2024. PMID: 38675679 Free PMC article. Review.
NASH and cardiovascular disease (CVD) have common risk factors, but compared to liver-related causes, the most common cause of death in NASH patients is CVD. ...In this review, we used "statin", "NAFLD", "NASH", and "CVD" as the major key …
NASH and cardiovascular disease (CVD) have common risk factors, but compared to liver-related causes, the most common c …
Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.
Boccatonda A, Del Cane L, Marola L, D'Ardes D, Lessiani G, di Gregorio N, Ferri C, Cipollone F, Serra C, Santilli F, Piscaglia F. Boccatonda A, et al. Life (Basel). 2024 Apr 4;14(4):473. doi: 10.3390/life14040473. Life (Basel). 2024. PMID: 38672744 Free PMC article. Review.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is not only related to traditional cardiovascular risk factors like type 2 diabetes mellitus and obesity, but it is also an independent risk factor for the development of cardiovascular disease. MASLD …
Metabolic dysfunction-associated steatotic liver disease (MASLD) is not only related to traditional cardiovascular risk factors like type 2 …
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics.
Kounatidis D, Vallianou NG, Geladari E, Panoilia MP, Daskou A, Stratigou T, Karampela I, Tsilingiris D, Dalamaga M. Kounatidis D, et al. Biomedicines. 2024 Apr 9;12(4):826. doi: 10.3390/biomedicines12040826. Biomedicines. 2024. PMID: 38672181 Free PMC article. Review.
Therefore, several non-invasive scores may be applied to more easily diagnose and monitor NAFLD. In this review, we discuss the various biomarkers and imaging scores that could be useful in diagnosing and managing NAFLD. Despite the fact that general measures, such …
Therefore, several non-invasive scores may be applied to more easily diagnose and monitor NAFLD. In this review, we discuss the vario …
Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations.
Long C, Zhou X, Xia F, Zhou B. Long C, et al. Biology (Basel). 2024 Apr 6;13(4):243. doi: 10.3390/biology13040243. Biology (Basel). 2024. PMID: 38666855 Free PMC article. Review.
As a multisystem disease, NAFLD is closely associated with systemic insulin resistance, central obesity, and metabolic disorders, which contribute to its pathogenesis and the development of extrahepatic complications, such as cardiovascular disease (CVD), typ …
As a multisystem disease, NAFLD is closely associated with systemic insulin resistance, central obesity, and metabolic disorders, whi …
Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics.
Singh V, Mahra K, Jung D, Shin JH. Singh V, et al. Probiotics Antimicrob Proteins. 2024 Apr 22. doi: 10.1007/s12602-024-10262-y. Online ahead of print. Probiotics Antimicrob Proteins. 2024. PMID: 38647957 Review.
Thus, in women with PCOS, dysbiosis can promote the progression and severity of type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and cardiovascular diseases (CVD). To alleviate such PCOS-associated complications, microbial therapeutics (probiotics and fecal micr …
Thus, in women with PCOS, dysbiosis can promote the progression and severity of type 2 diabetes, non-alcoholic fatty liver disease (NAFLD …
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.
Al Hashmi K, Giglio RV, Pantea Stoian A, Patti AM, Al Waili K, Al Rasadi K, Ciaccio M, Rizzo M. Al Hashmi K, et al. Front Nutr. 2024 Mar 19;11:1355732. doi: 10.3389/fnut.2024.1355732. eCollection 2024. Front Nutr. 2024. PMID: 38567250 Free PMC article. Review.
The definition of "Metabolic Associated Fatty Liver Disease - MAFLD" has replaced the previous definition of Nonalcoholic Fatty Liver Disease (NAFLD), because cardiometabolic criteria have been added for the prevention of cardiological risk in these patients. This definiti …
The definition of "Metabolic Associated Fatty Liver Disease - MAFLD" has replaced the previous definition of Nonalcoholic Fatty Liver Diseas …
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.
Mahmoudi SK, Tarzemani S, Aghajanzadeh T, Kasravi M, Hatami B, Zali MR, Baghaei K. Mahmoudi SK, et al. Eur J Med Res. 2024 Mar 20;29(1):190. doi: 10.1186/s40001-024-01708-8. Eur J Med Res. 2024. PMID: 38504356 Free PMC article. Review.
Hepatic steatosis can progress to more severe forms of NAFLD, including NASH and cirrhosis. It also may develop secondary diseases such as diabetes and cardiovascular disease. ...Additionally, it explains the role of the genetic components in the induc …
Hepatic steatosis can progress to more severe forms of NAFLD, including NASH and cirrhosis. It also may develop secondary dise …
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence.
Vallianou NG, Kounatidis D, Psallida S, Panagopoulos F, Stratigou T, Geladari E, Karampela I, Tsilingiris D, Dalamaga M. Vallianou NG, et al. Curr Nutr Rep. 2024 Mar 1. doi: 10.1007/s13668-024-00521-3. Online ahead of print. Curr Nutr Rep. 2024. PMID: 38427291 Review.
We will discuss the significance of dietary choline in cardiometabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD), and chronic kidney disease (CKD) as well as in cognitive function and associated neuropsychiatri …
We will discuss the significance of dietary choline in cardiometabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), …
The Global Epidemic of Metabolic Fatty Liver Disease.
Lee ECZ, Anand VV, Razavi AC, Alebna PL, Muthiah MD, Siddiqui MS, Chew NWS, Mehta A. Lee ECZ, et al. Curr Cardiol Rep. 2024 Apr;26(4):199-210. doi: 10.1007/s11886-024-02025-6. Epub 2024 Feb 20. Curr Cardiol Rep. 2024. PMID: 38376745 Review.
PURPOSE OF REVIEW: The objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD), its correlation with cardiovascular disease (CVD) outcomes, as well as to evaluate the u …
PURPOSE OF REVIEW: The objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associ …
700 results